Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by cannabiscon Jul 07, 2022 10:36am
226 Views
Post# 34808197

Investor Alert 🚨

Investor Alert 🚨

Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) (“Avant” or the “Company”), a leading producer of handcrafted, high quality cannabis products will release it's Q2 financial and operating results for the second quarter ended May 31, 2022, after the close of the Toronto Stock Exchange on Wednesday, July 13, 2022.


A conference call with management will be held on Thursday, July 14, 2022, at 1 PM PT (4 PM ET).

Avant has already boasted a 4.6M Q1

Another 4.6-5M Q2 will put us close to our entire 21' fiscal year in revenue of 11M.

With 3PL in full production now we are starting to see a pattern / guidence on doubling revenue Q over Q and Y over Y. 
 

Conservatively say (Q1) 4.6M x 4Q = $18.4M

 

Less $2.25 x 5,000 Kg packaged cost = $11.25M

 

Should leave $7.15M net profit @ 49% = $3.575M

 

Plus our "francise fee" from 3PL which is close to $1M a year. So + $4.575M 

 

Get these shares while there cheap now !!

<< Previous
Bullboard Posts
Next >>